-
Neal Shore, MD, FACS; Carolina Urologic Research Center 5Live #ASCO20
4:58
Key Insights on HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.
-
Expert Insights_New Treatments and New Targets for the Treatment of Prostate Cancer: Expanding Options Along the Disease Continuum
29:35
